Doxazosin effects insulin glucose hypertensive patients Finnish Multicenter Study Group study effects prolonged doxazosin treatment serum lipids glucose serum insulin blood pressure hypertensive patients weeks treatment doxazosin supine blood pressures final mean daily dose mg Blood glucose levels weeks initial placebo period weeks treatment doxazosin significant decrease serum insulin levels weeks treatment significant decrease weeks addition doxazosin significant reduction total cholesterol low-density lipoprotein LDL cholesterol weeks levels high-density lipoprotein HDL cholesterol very-low-density lipoprotein VLDL cholesterol triglycerides significant change tendency ratio HDL total cholesterol combined changes blood pressure blood glucose levels serum insulin serum lipids probability coronary heart disease CHD 